Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades912
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions2
HIK
Media
HIK Company
Research
HIK Company
Timeline2
Share Price Information for Hikma Pharmaceuticals (HIK)
Last checked at -
Last checked at 
Intraday Hikma Pharmaceuticals Share Chart
Hikma Pharmaceuticals News
LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance
LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance
Hikma lifts FY generics guidance as first-half profits, revenue jump
(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it h...
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
IN BRIEF: Arecor ends first half of 2021 with solid cash position
IN BRIEF: Arecor ends first half of 2021 with solid cash position
BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight
BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight
BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart
BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart
UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents
(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amar...
U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents
WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug...
Follow the stocks
